JPWO2021184062A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021184062A5 JPWO2021184062A5 JP2022555836A JP2022555836A JPWO2021184062A5 JP WO2021184062 A5 JPWO2021184062 A5 JP WO2021184062A5 JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP WO2021184062 A5 JPWO2021184062 A5 JP WO2021184062A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- peptide
- use according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 206010057190 Respiratory tract infections Diseases 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 241000711573 Coronaviridae Species 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 241000709661 Enterovirus Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 241000351643 Metapneumovirus Species 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 241000709664 Picornaviridae Species 0.000 claims 1
- 241000725643 Respiratory syncytial virus Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900807A AU2020900807A0 (en) | 2020-03-16 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020900807 | 2020-03-16 | ||
| AU2020900818 | 2020-03-17 | ||
| AU2020900818A AU2020900818A0 (en) | 2020-03-17 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020904226A AU2020904226A0 (en) | 2020-11-16 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020904226 | 2020-11-16 | ||
| PCT/AU2021/050229 WO2021184062A1 (en) | 2020-03-16 | 2021-03-16 | Compositions for treating respiratory tract infection and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518376A JP2023518376A (ja) | 2023-05-01 |
| JPWO2021184062A5 true JPWO2021184062A5 (enExample) | 2024-03-27 |
Family
ID=77767913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555836A Withdrawn JP2023518376A (ja) | 2020-03-16 | 2021-03-16 | 気道感染症を治療するための組成物およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230256059A1 (enExample) |
| EP (1) | EP4121084A4 (enExample) |
| JP (1) | JP2023518376A (enExample) |
| CN (1) | CN115297882A (enExample) |
| AU (1) | AU2021237981A1 (enExample) |
| CA (1) | CA3171917A1 (enExample) |
| WO (1) | WO2021184062A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114222582A (zh) * | 2019-07-09 | 2022-03-22 | 横向知识产权私人有限公司 | 肽及其用途 |
| AU2022269043A1 (en) * | 2021-05-07 | 2023-11-30 | Lateral Pharma Pty Ltd | Compositions for treating inflammatory airway disease and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20080333A0 (fi) * | 2008-05-02 | 2008-05-02 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| EP2788014B8 (en) * | 2011-12-09 | 2019-10-23 | Metabolic Pharmaceuticals Pty Ltd | Use of growth hormone fragments |
| SG11202006669RA (en) * | 2018-01-15 | 2020-08-28 | Lateral IP Pty Ltd | Peptides and uses thereof |
| AU2020410914A1 (en) * | 2019-12-27 | 2022-08-11 | Lateral IP Pty Ltd | Cyclic peptide receptor Lanthionine synthetase C-like protein (LANCL) and uses thereof |
-
2021
- 2021-03-16 EP EP21770411.3A patent/EP4121084A4/en not_active Withdrawn
- 2021-03-16 JP JP2022555836A patent/JP2023518376A/ja not_active Withdrawn
- 2021-03-16 CA CA3171917A patent/CA3171917A1/en active Pending
- 2021-03-16 WO PCT/AU2021/050229 patent/WO2021184062A1/en not_active Ceased
- 2021-03-16 US US17/911,972 patent/US20230256059A1/en active Pending
- 2021-03-16 CN CN202180021765.1A patent/CN115297882A/zh active Pending
- 2021-03-16 AU AU2021237981A patent/AU2021237981A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505046A5 (enExample) | ||
| JP2004538303A5 (enExample) | ||
| JP2008538115A5 (enExample) | ||
| AU2002351181B2 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| JP2014518268A5 (enExample) | ||
| US20090227511A1 (en) | Methods and compositions for treating lesions of the respiratory epithelium | |
| CN113304166A (zh) | 核苷类化合物在治疗冠状病毒感染性疾病中的用途 | |
| CN102325532A (zh) | 用于减轻肺部炎症的左氧氟沙星吸入剂 | |
| FI3710036T3 (fi) | Stabiileja askorbiinihappokoostumuksia ja menetelmiä niiden käyttämiseksi | |
| JP2002532520A (ja) | 気道病治療および気道用薬剤送達のための化合物および方法 | |
| Druce | Adjuncts to medical management of sinusitis | |
| JP2005537296A5 (enExample) | ||
| JPWO2021184062A5 (enExample) | ||
| TW200838556A (en) | Pharmaceutical composition for inhibiting the syndrome of snore and preparation thereof | |
| JP2020516689A5 (enExample) | ||
| JPWO2021191592A5 (enExample) | ||
| CN105770862A (zh) | 干扰素的干粉吸入剂 | |
| JP2010523662A5 (enExample) | ||
| Mäkelä et al. | Treatment of respiratory syncytial virus infections in children | |
| JP2003528133A5 (enExample) | ||
| JPWO2020240472A5 (enExample) | ||
| JPWO2020257248A5 (enExample) | ||
| RU2020120204A (ru) | Новые производные полиолов, их применение, фармацевтическая композиция на их основе | |
| JP2023524064A (ja) | ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法 | |
| JPWO2021138682A5 (enExample) |